Back to top

Analyst Blog

CooperSurgical, a part of The Cooper Companies (COO - Analyst Report), a company focused on contact lens and women’s health, recently revealed the launch of its Carter-Thomason II Port Closure System. This system allows rapid and safe closure of port sites for obese to regular patients going through a variety of laparoscopic operations. It has two constituent parts, namely the Suture Guide and the sophisticated Suture Passer.  

The Suture Guide ensures total closure including for peritoneum and fascia. This methodology preserves the pneumoperitoneum and allows precise positioning of the Suture Passer for steady outcomes with each closure.  

The latest Suture Passer comes with a new and improved design with extended and retractable fingers. It permits doctors to implement over a larger area for safer and faster recovery of sutures in the abdomen.  

The Carter-Thomason II Port Closure System permits accurate closure of fascia for a range of patients, ranging from average to those with morbid obesity. This prevents the occurrence of herniation at point of port location, which is a possible complication arising from minimally invasive procedures.

Cooper is a global medical products company specializing in a wide range of contact lenses for the vision correction market with a smaller strategic business unit for women’s health. It reportedly holds the number three position in the $6 billion global contact lens industry.

The outlook for the contact lens industry is favorable. Cooper has significant market share in high growth specialty lenses.

The company is a leader in the high-margin toric lens market. It offers multiple designs of toric lenses across a wide range of parameters, unlike some of its competitors, who offer toric lenses in a limited number of designs.

However, Cooper faces formidable competition in each of its major product lines. Competition comes from well established global contact lens makers such as Johnson & Johnson (JNJ - Analyst Report) and Novartis AG (NVS - Analyst Report). Depressed levels of consumer spending have heightened the competitive pressures on the company.

Our Outperform recommendation is supported by a short-term Zacks #2 Rank (Buy).

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
PLANAR SYST… PLNR 4.44 +5.21%
BITAUTO HOL… BITA 81.71 +5.12%
CTPARTNERS… CTP 16.66 +4.26%
CHINA BIOLO… CBPO 47.91 +3.30%
MALLINCKROD… MNK 72.94 +2.85%